Literature DB >> 25225350

Death: a foe to be conquered? Questioning the paradigm.

Anthea Gellie1, Amber Mills2, Michele Levinson2, Gemma Stephenson2, Eleanor Flynn3.   

Abstract

There are few certainties in life-death is one of them. Yet death is often thought of today as the 'loss of the battle' against illness, where in traditional societies it was the natural, meaningful, end to life. Medical knowledge and technologies have extended the possibilities of medical care and increased our life span. People living in most developed countries today can expect to survive to an advanced age and die in hospital rather than at home as in the past. Owing to these and other historical, cultural and social factors, our views on death have been skewed. Medical technology provides an arsenal of weapons to launch against death and the 'war against disease' has entrenched itself in medical philosophy. We now primarily experience death through the lens of a camera. Representations of 'death as spectacle' distort our perceptions and leave us ill-prepared for the reality. Additionally, death as a natural consequence of life has become much less visible than it was in the past due to our longer life expectancies and lack of infectious disease. The continued thrust for treatment, wedded with a failure to recognise the dying process, can rob individuals of a peaceful, dignified death. Progress being made in Advance Care Planning and palliative care is limited by the existing paradigm of death as a 'foe to be conquered'. It is time for a shift in this paradigm.
© The Author 2014. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ageing; attitude to death; care goals; death; end of life care; older people; terminal care

Mesh:

Year:  2014        PMID: 25225350     DOI: 10.1093/ageing/afu116

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  7 in total

1.  The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1.

Authors:  Daniel N Meijles; Sanghamitra Sahoo; Imad Al Ghouleh; Jefferson H Amaral; Raquel Bienes-Martinez; Heather E Knupp; Shireen Attaran; John C Sembrat; Seyed M Nouraie; Mauricio M Rojas; Enrico M Novelli; Mark T Gladwin; Jeffrey S Isenberg; Eugenia Cifuentes-Pagano; Patrick J Pagano
Journal:  Sci Signal       Date:  2017-10-17       Impact factor: 8.192

2.  End of life care preferences among people of advanced age: LiLACS NZ.

Authors:  Merryn Gott; Rosemary Frey; Janine Wiles; Anna Rolleston; Ruth Teh; Tess Moeke-Maxwell; Ngaire Kerse
Journal:  BMC Palliat Care       Date:  2017-12-19       Impact factor: 3.234

3.  Persistent inequalities in Hospice at Home provision.

Authors:  Jackie Buck; Liz Webb; Lorraine Moth; Lynn Morgan; Stephen Barclay
Journal:  BMJ Support Palliat Care       Date:  2018-02-14       Impact factor: 3.568

4.  Words describing feelings about death: A comparison of sentiment for self and others and changes over time.

Authors:  Lauren R Miller-Lewis; Trent W Lewis; Jennifer Tieman; Deb Rawlings; Deborah Parker; Christine R Sanderson
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

5.  Last Aid Course-The Slovenian Experience.

Authors:  Erika Zelko; Larisa Vrbek; Melita Koletnik
Journal:  Healthcare (Basel)       Date:  2022-06-21

6.  The contribution of a MOOC to community discussions around death and dying.

Authors:  Jennifer Tieman; Lauren Miller-Lewis; Deb Rawlings; Deborah Parker; Christine Sanderson
Journal:  BMC Palliat Care       Date:  2018-02-20       Impact factor: 3.234

7.  Translation and Cultural Adaptation into Portuguese of the Quality of Dying and Death Scale for Family Members of Patients in Intensive Care Units.

Authors:  Silmara Meneguin; Cariston Rodrigo Benichel; José Fausto Morais; Cesar de Oliveira
Journal:  Int J Environ Res Public Health       Date:  2022-03-18       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.